Endocrinology

When taken early in a pregnancy, mifepristone can end a pregnancy that is less than 49 days along. Another notable trait of the drug, though, is its ability to control the high blood sugar in patients with Cushing syndrome who have type 2 diabetes and have either failed surgery or are not candidates for it.

New data has elucidated a mechanism of action by which hormonal replacement therapy could help prevent T2D in women after menopause.

Researchers note that efforts are needed to align clinical practice with clinical guidelines.

Study results showed significant HbA1c reduction when Bydureon was added to insulin glargine therapy versus insulin glargine alone.

The Beyond Type 1 Science Advisory Council member explains the warning signs of diabetes.

Doctors of osteopathic medicine have long sought to be viewed equally in the eyes of their colleagues, but their differences may have helped shape modern medicine. Does stigma still exist?

The device is the first of its class and will be designated as a class II device, subjecting it to special controls that will serve as criteria for future devices.

The Max SoloStar from Sanofi is capable of carrying 300 units/mL of insulin glargine, and administer 160 units/mL in a single injection.

This week on MDNN: America trends toward healthier outcomes, the first-ever gene therapy procedure was performed, and President Donald Trump declared his stance on opioid traffickers.

Integrating transgender-specific content into medical curricula improves student knowledge and comfort with transgender medical care.

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

Pregnant women with polycystic ovary syndrome taking metformin were 5% less likely to experience a miscarriage or preterm birth compared to those on placebo.

The GLP-1 receptor agonist is a similar, longer-acting formula to that of liraglutide, another successful therapy from Novo Nordisk that was recently approved for its second indication of lowering cardiovascular risk.

Adults with obesity treated with semaglutide 0.4 mg lost up to 13.8% of body weight after 52 weeks, significantly more weight than those treated with placebo who lost 2.3%.

The device will offer real-time tracking and alerts for glucose level high and low events, as well as telemedicine capabilities.

A joint statement from the Endocrine Society, the ADA, the AACE, and the AADE expressed strong disagreement with the ACP’s new guidelines, which raised goal A1C levels to between 7% and 8% for patients with T2D.

The therapies come on the tail of Amgen's failed attempt to receive a 6-month exclusivity extension for Sensipar.

The updated guidelines state that patients should be treated to achieve A1C levels between 7% and 8%.

A new classification of diabetes may provide information about underlying disease mechanisms and ultimately guide the choice of therapy.

Carb counting, bar-code recognition, log-book, exercise tracker, insulin calculator -- and more, all in each one of these 5 apps.

Medtronic had both its Guardian Sensor 3 CGM system and it's Resolute Onyx 2.0 mm drug-eluting stent approved by the FDA.

A rare genetic condition has been linked to the development of both diabetes and insulinomas in a single family.

Higher rates of stillbirths, the need for emergency Caesarean sections, and infant mortality have all been associated with both type 1 and type 2 diabetes

The Dermapace System is intended for adults at least 22 years old, with diabetic foot ulcers lasting more than 30 days.

The risk of major birth defects was 6% higher due to a diagnosis of pre-gestational diabetes than without the presence of the condition.

Findings indicated that Macrilen stimulated the pituitary gland to produce the growth hormone more effectively than the ITT.

Ertugliflozin, an SGLT2 inhibitor from Merck & Co. and Pfizer, was approved as both a monotherapy and fixed-dose combination therapy.